Upper Limb Spasticity clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for

  • Dysport® and Botox® in Adults With Upper Limb Spasticity.

    Sorry, in progress, not accepting new patients

    This study is aiming to demonstrate the non-inferiority of AbobotulinumtoxinA (aboBoNT-A) versus OnabotulinumtoxinA (onaBoNT-A) as the primary safety endpoint, and the superiority of aboBoNT-A over onaBoNT-A with respect to duration of response as the key secondary efficacy endpoint when used at optimal doses according to approved prescribing information of each product.

    at UCLA

Our lead scientists for Upper Limb Spasticity research studies include .

Last updated: